Back

In-vivo Efficacy of a Phage Cocktail Therapy that Targets ESBL-producing Klebsiella Urinary Tract Infections Clinical Isolates

Jariah, R. O. A.; Schofield, J.; West, K.; Michniewski, S.; Jameson, E.; Onions, L.; Saravanan, A.; Yesilkaya, H.; Millard, A. D.; Clokie, M. R. J.; Haines, M. E. K.

2025-04-01 microbiology
10.1101/2025.04.01.646603 bioRxiv
Show abstract

Uropathogenic Klebsiella pneumoniae strains, are of major concern of with respect to antimicrobial resistance, which has sparked interest in phage therapy as an alternative, or compliment to antibiotics. However, very limited in vivo data on phage therapy safety and efficacy for treating UTIs is available. To address this, we developed a model to test these parameters for a phage cocktail optimised for Extended Spectrum Beta-Lactamases (ESBL)-producing Klebsiella UTI strains. Female C57BL/6J mice were infected with K. pneumoniae Top52 then received a single dose of the purified therapeutic phages, with observations over seven days. Results showed a significant reduction of bacterial burden in urine, bladder, and kidney samples starting from 4 h post-treatment until Day 7. Phage treatment also reduced local inflammation within the bladder. Additionally, cytokine profile demonstrated an increase in anti-inflammatory IL-10 and a decrease in pro-inflammatory IL-6, indicating a synergy between phage and the host immune response.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Infection and Immunity
● 120 papers in training set
Top 0.1%
15.1%
Similar papers in this journal
2
Antimicrobial Agents and Chemotherapy
● 187 papers in training set
Top 0.3%
11.9%
Similar papers in this journal
3
Microbiology Spectrum
● 469 papers in training set
Top 0.7%
11.0%
Similar papers in this journal
4
Antibiotics
○ 34 papers in training set
Top 0.1%
6.7%
Similar papers in this journal
5
mBio
● 833 papers in training set
Top 4%
4.0%
Similar papers in this journal
6
PLOS ONE
● 5266 papers in training set
Top 34%
3.4%
50% of probability mass above
7
mSphere
● 302 papers in training set
Top 2%
2.8%
8
mSystems
● 394 papers in training set
Top 3%
2.8%
9
Microbiology
● 65 papers in training set
Top 0.5%
2.4%
10
Journal of Applied Microbiology
◐ 20 papers in training set
Top 0.2%
2.4%
11
Frontiers in Immunology
○ 638 papers in training set
Top 5%
2.4%
12
Scientific Reports
○ 3612 papers in training set
Top 46%
2.1%
13
Frontiers in Microbiology
○ 427 papers in training set
Top 5%
1.9%
14
Journal of Clinical Microbiology
● 130 papers in training set
Top 0.8%
1.7%
15
Frontiers in Medicine
○ 120 papers in training set
Top 2%
1.7%
16
Journal of Antimicrobial Chemotherapy
◐ 46 papers in training set
Top 0.6%
1.7%
17
Viruses
○ 332 papers in training set
Top 3%
1.5%
18
Microbiological Research
○ 22 papers in training set
Top 0.3%
1.5%
19
PLOS Neglected Tropical Diseases
● 466 papers in training set
Top 4%
1.5%
20
Frontiers in Cellular and Infection Microbiology
○ 109 papers in training set
Top 2%
1.5%
21
eLife
● 5828 papers in training set
Top 59%
1.1%
22
The Journal of Infectious Diseases
◐ 202 papers in training set
Top 3%
1.1%
23
PLOS Pathogens
● 820 papers in training set
Top 8%
1.0%
24
Applied and Environmental Microbiology
● 339 papers in training set
Top 5%
0.8%
25
International Journal of Antimicrobial Agents
○ 15 papers in training set
Top 0.4%
0.8%
26
JCI Insight
● 277 papers in training set
Top 9%
0.6%
27
Microorganisms
○ 106 papers in training set
Top 4%
0.6%
28
npj Antimicrobials and Resistance
○ 11 papers in training set
Top 0.2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.